News / Uncategorized
This next-generation CRISPR company is on the rise…
This next-generation CRISPR company is on the rise…
August 21, 2023
Scribe Therapeutics – a company spun out of UC Berkeley – just raised $100 million in a Series B venture capital (VC) round. This is a follow-on to Scribe’s $20 million Series A round back in October of last year. I have been tracking Scribe since the company got started back in 2019.
That’s because Jennifer Doudna is one of its founders. If we remember, Doudna won the Nobel Prize last year for her early work on CRISPR genetic editing technology. Anything she is working on is worth keeping an eye on. And Scribe’s approach is interesting. The company is using computational biology to create new enzymes for use in CRISPR therapies. Enzymes are the delivery mechanism for getting the therapy to the cells that need to be edited.
So Scribe’s focus is to optimize CRISPR enzymes. This will open the door to all kinds of new therapies. Each enzyme will be tailored for different disease targets. And Scribe’s first engineered enzyme is called CasX. CasX is smaller than the Cas9 enzyme that many of the first-generation CRISPR therapies use. Scribe believes that the CasX enzyme will be perfectly suited to tackle neurodegenerative diseases that have been extremely difficult to treat with traditional therapies.
I’m very excited to see the company’s full development pipeline when it is released. And what’s remarkable here is that there is absolutely no competition in the space. The development of new CRISPR enzymes represents a greenfield opportunity. It’s a new technology that will create cures for diseases that have been untreatable up to this point. We will definitely want to keep a close eye on Scribe going forward.
I suspect that this company will move quickly given its approach. This company is doing some great work. Let’s make sure we have it on our early stage watchlist.
Share this article:
More in Uncategorized:
Ultra Clean Holdings (UCTT) July 25, 2024, Earnings Call Summary
Future Price Projections Participants: Rhonda Bennetto – Senior Vice President, Investor Relations Jim Scholhamer – Chief Executive Officer Sheri Savage...
This next-generation CRISPR company is on the rise…
July 26, 2024
APPLE, MICROSOFT, NVIDIA PRICE TARGET 🎯
Short term, price targets for the top three S&P 500 holdings
Short term, price targets for the top three S&P 500 holdings The following are my price targets for the very...
![Trent Grinkmeyer in front of stock market with bull background](https://bestofusinvestors.com/uploads/2023/06/trent-e1687263019450-300x300.webp)
Trent Grinkmeyer
July 25, 2024
Nvidia's Stake in Serve Robotics: A Game-Changer for AI-Powered Delivery?
The tech world was buzzing last week when news broke that AI chip giant Nvidia owns a 10% stake in Serve Robotics, a company specializing in autonomous sidewalk delivery robots. This revelation sent Serve's stock soaring an impressive 233% over two days. But what does this mean for the future of AI-powered delivery, and should investors jump on board?
The tech world was buzzing last week when news broke that AI chip giant Nvidia owns a 10% stake in...
![Trent Grinkmeyer in front of stock market with bull background](https://bestofusinvestors.com/uploads/2023/06/trent-e1687263019450-300x300.webp)
Trent Grinkmeyer
July 24, 2024
The Commercial Real Estate Crash
Its Ripple Effect on the Banking System and The Stock Market
The commercial real estate market is on the verge of a significant downturn, potentially mirroring the infamous 2008 financial crisis....
This next-generation CRISPR company is on the rise…
July 23, 2024
The Democratization of Compute
A Paradigm Shift in Business and Investment Artificial Intelligence (AI) is undeniably transformative, poised to revolutionize the world as we...
![Kerry Grinkmeyer in a suit standing in front of a stock chart with a bull on it](https://bestofusinvestors.com/uploads/2023/07/kerry-300x300.webp)
Kerry Grinkmeyer
July 23, 2024
Are Google and Meta Heading for a Stock Price Slump?
As an investor, it's crucial to keep a keen eye on market trends and potential shifts that could impact major players. Today, I want to discuss two tech giants that have long been darlings of Wall Street: Google and Meta. While they've enjoyed impressive growth and dominance in their respective fields, there are signs that their stock prices might face some headwinds in the near future.
As an investor, it's crucial to keep a keen eye on market trends and potential shifts that could impact major...
![Trent Grinkmeyer in front of stock market with bull background](https://bestofusinvestors.com/uploads/2023/06/trent-e1687263019450-300x300.webp)
Trent Grinkmeyer
July 23, 2024